About: Tumor vaccination using messenger RNA: prospects of a future therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Tumor vaccination using messenger RNA: prospects of a future therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 13 April 2011

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) наукова стаття, опублікована у квітні 2011 (uk) مقالة علمية نشرت في 13 أبريل 2011 (ar) scientific article published on 13 April 2011 (en) artículu científicu espublizáu n'abril de 2011 (ast)
publication date	wds:Q37865772-855AE78E-74C1-4BF5-8D09-68264A223584
publication date	2011-04-13 00:00:00Z (xsd:dateTime)
rdfs:label	Tumor vaccination using messenger RNA: prospects of a future therapy (en) Tumor vaccination using messenger RNA: prospects of a future therapy (nl)
skos:prefLabel	Tumor vaccination using messenger RNA: prospects of a future therapy (en) Tumor vaccination using messenger RNA: prospects of a future therapy (nl)
name	Tumor vaccination using messenger RNA: prospects of a future therapy (en) Tumor vaccination using messenger RNA: prospects of a future therapy (nl)
author	wds:Q37865772-06C22E35-434B-4404-ACE2-6C26FD3E7159 wds:Q37865772-1D084D49-97F7-47A2-B7CD-FABF9BE5DF8D wds:Q37865772-AA7E3006-E28F-4075-A3E5-7979D613F84F wds:Q37865772-B823A53F-51C1-4EE8-A465-84FF9572B628 wds:Q37865772-DA4CAD85-4738-4031-9603-E211CB66FA5A
author	Özlem Türeci Uğur Şahin Sebastian Kreiter Mustafa Diken Abderraouf Selmi
title	wds:Q37865772-38E56AB3-391C-4374-BCBF-261BA8983B8B
title	Tumor vaccination using messenger RNA: prospects of a future therapy (en)
page(s)	wds:Q37865772-E3841D6F-4ECB-4252-9AC7-D0AA47B938E1
page(s)	399-406
instance of	wds:Q37865772-3c901d2b-c16c-48b0-81f7-23528226120a wds:Q37865772-851721B1-C802-4769-B4FE-898C8B1B3E27
instance of	review article scholarly article
PubMed ID	wds:Q37865772-F7848C1F-E92D-44FC-98A8-1A49FC083298
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21497074
PubMed ID	21497074
published in	wds:Q37865772-4E1E9979-62D8-4B2D-9121-99A446D16566
published in	Current Opinion in Immunology
issue	wds:Q37865772-B4E47D6A-B675-4842-8D71-499361B2752F
volume	wds:Q37865772-C4326D29-ABA0-4FB7-9A5F-CAB345F7F265
issue	3
volume	23
DOI	wds:Q37865772-B775CFB5-6D0C-4CC0-8137-8984170A0B78
DOI	http://dx.doi.org/10.1016/J.COI.2011.03.007
DOI	10.1016/J.COI.2011.03.007
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37865772
is cites work of	Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin Inhibition of Xenograft tumor growth by gold nanoparticle-DNA oligonucleotide conjugates-assisted delivery of BAX mRNA Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose RNA-based vaccines Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines Messenger RNA (mRNA) nanoparticle tumour vaccination Therapeutic cancer vaccines. mRNA-based therapeutics--developing a new class of drugs HLA typing from RNA-Seq sequence reads A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs Potential therapeutic applications of RNA cap analogs. Translation of genomics-guided RNA-based personalised cancer vaccines: towards the bedside RNA pulsed dendritic cells: an approach for cancer immunotherapy mRNA leapfrogs DNA to show promise for therapeutic gene transfer Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines. mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic. Designing vaccines for the twenty-first century society mRNA transcript therapy Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles. New approach in RNA quantification using arginine-affinity chromatography: potential application in eukaryotic and chemically synthesized RNA. Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges Messenger RNA-based vaccines: progress, challenges, applications Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA. Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma Optimizing the process of nucleofection for professional antigen presenting cells Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice. Use of antigen-primed dendritic cells for inducing antitumor immune responses in vitro in patients with non-small cell lung cancer. RNA mediated Toll-like receptor stimulation in health and disease Self-replicating alphavirus RNA vaccines. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems Electroporated Antigen-Encoding mRNA Is Not a Danger Signal to Human Mature Monocyte-Derived Dendritic Cells. Incorporation of Synthetic mRNA in Injectable Chitosan-Alginate Hybrid Hydrogels for Local and Sustained Expression of Exogenous Proteins in Cells. Chronic Myelocytic Leukemia (CML) Patient-Derived Dendritic Cells Transfected with Autologous Total RNA Induces CML-Specific Cytotoxicity. Smart micelleplexes as a new therapeutic approach for RNA delivery Multi-experiment nonlinear mixed effect modeling of single-cell translation kinetics after transfection Multi-experiment nonlinear mixed effect modeling of single-cell translation kinetics after transfection. Viral and Synthetic RNA Vector Technologies and Applications Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies Vectors and strategies for nonviral cancer gene therapy Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination. Luciferase mRNA Transfection of Antigen Presenting Cells Permits Sensitive Nonradioactive Measurement of Cellular and Humoral Cytotoxicity.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software